SSWM
PLX icon

Smith Salley Wealth Management’s Protalix BioTherapeutics PLX Stock Holding History

Smith Salley Wealth Management’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,048
Closed -$16.5K – 232
2022
Q4 		$16.5K Hold
12,048
– – ﹤0.01% 222
2022
Q3 		$13K Hold
12,048
– – ﹤0.01% 213
2022
Q2 		$13K Hold
12,048
– – ﹤0.01% 227
2022
Q1 		$13K Buy
+12,048
New +$13K ﹤0.01% 239